title: [Bortezomib-based four-drug combination regimen improved the efficacy of multiple myeloma patients receiving previous doublet or triplet regimens containing Bortezomib].
authors.affiliation: Department of Hematology, The First Affiliated Hospital, Sun Yat- sen University, Guangzhou 510080, China.
authors.forename: Junru
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Hematology, The First Affiliated Hospital, Sun Yat- sen University, Guangzhou 510080, China.
authors.forename: Juan
authors.initials: J
authors.lastname: Li
authors.affiliation: Department of Hematology, The First Affiliated Hospital, Sun Yat- sen University, Guangzhou 510080, China.
authors.forename: Dong
authors.initials: D
authors.lastname: Zheng
mesh_terms: D000069286:Bortezomib / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D000069286:Bortezomib